SILVER SPRING, Md., March 4, 2025 /PRNewswire/ -- Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: On Monday, the FDA approved the first generics of Xarelto (rivaroxaban), 2.5 mg, tablets to reduce the risk of major...
FDA Roundup: March 4, 2025
Seeking Alpha / 4 hours ago 1 Views
Comments